Q2 2016 13F Holders as of 6/30/2016
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
162M
-
Number of holders
-
139
-
Total 13F shares, excl. options
-
135M
-
Shares change
-
-4.05M
-
Total reported value, excl. options
-
$1.77B
-
Value change
-
-$48.3M
-
Put/Call ratio
-
1.57
-
Number of buys
-
77
-
Number of sells
-
-49
-
Price
-
$13.07
Significant Holders of IRONWOOD PHARMACEUTICALS INC - COMMON-STOCK (IRWD) as of Q2 2016
164 filings reported holding IRWD - IRONWOOD PHARMACEUTICALS INC - COMMON-STOCK as of Q2 2016.
IRONWOOD PHARMACEUTICALS INC - COMMON-STOCK (IRWD) has 139 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 135M shares
of 162M outstanding shares and own 83.7% of the company stock.
Largest 10 shareholders include FMR LLC (19.3M shares), WELLINGTON MANAGEMENT GROUP LLP (18M shares), JANUS CAPITAL MANAGEMENT LLC (14.2M shares), ORBIMED ADVISORS LLC (9.95M shares), VANGUARD GROUP INC (9.38M shares), PRICE T ROWE ASSOCIATES INC /MD/ (7.5M shares), BRIDGER MANAGEMENT, LLC (5.92M shares), BlackRock Fund Advisors (5.51M shares), Consonance Capital Management LP (4.93M shares), and BlackRock Institutional Trust Company, N.A. (3.29M shares).
This table shows the top 139 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.